(Press-News.org) New oral anticoagulant drugs that treat and prevent clots offer a much-needed alternative to warfarin, which has been used for more than 6 decades and has serious shortcomings. A new article published in BJS (British Journal of Surgery) gives an overview of the major clinical trials and recommendations related to these new agents and will serve as a practical guide for their use in patients who require planned or emergency surgery.
Warfarin has been the drug of choice to control blood clots in a variety of patients, including people with certain types of irregular heartbeats, people with prosthetic heart valves, and people who have suffered heart attacks. Unfortunately, warfarin has serious side-effects, requires frequent monitoring to reduce the risk of bleeding, and has interactions with multiple drugs and foods. New oral anticoagulant drugs—Apixaban, Dabigatran, and Rivaroxaban —offer safer alternatives to warfarin, but there are currently no markers for measuring activity levels of the drugs and there are no antidotes to reverse or neutralize their effects.
Aida Lai, MBChB, of the North Bristol NHS Trust in the UK, and her colleagues searched the medical literature and analysed studies published between January 2000 and January 2014 that reported on the use of new oral anticoagulant drugs. "As these drugs are still relatively new in the market, knowledge about how they work and their associated bleeding risks are still limited in the medical and surgical community," said Dr Lai. "Our review covers recommendation for the discontinuation of new oral anticoagulant drugs before surgical procedures and resuming of these drugs after procedures." The review also notes that because the drugs are eliminated by the kidneys, they require dose reductions dependent on a patient's kidney function. Also, new oral anticoagulants are not recommended in patients with severe liver dysfunction. And because the three drugs have somewhat different properties, one of the drugs may be better suited to a particular patient than the others.
"It is anticipated that in the near future these drugs would replace warfarin to a large extent," said Dr Lai. "Therefore our article is highly relevant to surgeons and any medical professional treating patients on these drugs."
INFORMATION:
Review offers insight on managing surgical patients who are taking new drugs to prevent blood clots
2014-04-29
ELSE PRESS RELEASES FROM THIS DATE:
Live virus implicates camels in MERS outbreak
2014-04-29
There is new, more definitive evidence implicating camels in the ongoing outbreak of Middle East Respiratory Syndrome, or MERS. Scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health, King Saud University, and EcoHealth Alliance extracted a complete, live, infectious sample of MERS coronavirus from two camels in Saudi Arabia. The sample matched MERS coronavirus (MERS-CoV) found in humans, indicating that the virus in camels is capable of infecting humans and that camels are a likely source of the outbreak.
Results ...
Low cholesterol in immune cells tied to slow progression of HIV
2014-04-29
PITTSBURGH, April 29, 2014 – People infected with HIV whose immune cells have low cholesterol levels experience much slower disease progression, even without medication, according to University of Pittsburgh Graduate School of Public Health research that could lead to new strategies to control infection.
The Pitt Public Health researchers found that low cholesterol in certain cells, which is likely an inherited trait, affects the ability of the body to transmit the virus to other cells. The discovery, funded by the National Institutes of Health (NIH), is featured in today's ...
Low cholesterol in immune cells slows HIV progression
2014-04-29
Scientists at the University of Pittsburgh have identified why some HIV-infected people experience much slower disease progression, even without medication, and it has to do with cholesterol levels in specific immune cells. They report their findings in mBio®, the online open-access journal of the American Society for Microbiology.
"A fascinating aspect of the AIDS epidemic is that a small percentage of HIV-1-infected persons, termed nonprogressors or controllers, maintain a relatively normal number of CD4 T cells (Th cells) and low viral load for many years without ...
When harm done can never be balanced: Vicarious revenge and the death of Osama bin Laden
2014-04-29
April 29, 2014 – Friday will mark the third anniversary of Osama bin Laden's assassination, a day when U.S. President Barack Obama famously stated "Justice has been done." But has it? A new study from a team of social psychology researchers led by Mario Gollwitzer of Philipps University of Marburg, has questioned whether this instance of vicarious revenge led to feelings of satisfaction and reestablished justice within the American public, including whether bin Laden's assassination ignited craving for more revenge.
Justice achieved
Vicarious revenge, where the need ...
Snobby staff can boost luxury retail sales
2014-04-29
When it comes to luxury brands, the ruder the sales staff the better the sales, according to new research from the University of British Columbia's Sauder School of Business.
The forthcoming Journal of Consumer Research study reveals that consumers who get the brush-off at a high-end retailer can become more willing to purchase and wear pricey togs.
"It appears that snobbiness might actually be a qualification worth considering for luxury brands like Louis Vuitton or Gucci," says Sauder Marketing Professor Darren Dahl. "Our research indicates they can end up having ...
NIH center sets new goals for global health research and training
2014-04-29
Global health research and training efforts should focus on combatting the growing epidemic of noncommunicable diseases, better incorporating information technology into research and training, and more effectively converting scientific discoveries into practice in low-resource settings, according to the Fogarty International Center's new strategic plan, released today. Fogarty is the component of the National Institutes of Health solely focused on supporting global health research and training, and coordinating international research partnerships across the agency.
As ...
Study of stem cell trials links discrepancies in data with reported success of treatment
2014-04-29
New research looking at the success of clinical trials of stem cell therapy shows that trials appear to be more successful in studies where there are more discrepancies in the trial data.
Researchers from Imperial College London conducted a meta-analysis of 49 randomised controlled trials of bone marrow stem cell therapy for heart disease. The study, published today in the British Medical Journal, identified and listed over 600 discrepancies within the trial reports.
Discrepancies were defined as two (or more) reported facts that could not both be accurate because ...
Annals of Internal Medicine tip sheet for April 29, 2014
2014-04-29
1. Viral hepatitis remains a major health concern in the U.S.
Experts comment on HHS 2014-2016 Viral Hepatitis Action Plan
Untreated chronic viral hepatitis affects between 3.5 and 5.3 million Americans and continues to fuel rising incidences of progressive liver disease, liver failure, and liver cancer. In 2011, the U.S. Department of Health and Human Services (HHS) unveiled the nation's first coordinated national approach to tackling viral hepatitis with the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis in the United States. Priorities set ...
AAN issues findings on use of medical marijuana in treatment of certain brain diseases
2014-04-28
MINNEAPOLIS – A review by the American Academy of Neurology of available scientific research on the use of medical marijuana in brain diseases finds certain forms of medical marijuana can help treat some symptoms of multiple sclerosis (MS), but do not appear to be helpful in treating drug-induced (levodopa) movements in Parkinson's disease. Not enough evidence was found to show if medical marijuana is helpful in treating motor problems in Huntington's disease, tics in Tourette syndrome, cervical dystonia and seizures in epilepsy. The review is published in the April 29, ...
Surveys indicate decline in children's exposure to violence
2014-04-28
Children's exposure to violence and crime declined between 2003 and 2011.
Rates of violent crime have declined in the United States since the 1990s. The authors previously completed three national telephone surveys of children and caregivers on children's exposure to violence in 2003, 2008 and 2011.
In this study, the authors analyzed the surveys for changes over time from 2003 to 2011.
The authors examined 50 specific trends in exposures to violence and crime and found 27 significant declines and no significant increases between 2003 and 2011. There were declines ...